News: | ||||
ITUS announced they have settled 15 cases in their J-Channel | ||||
portfolio. | ||||
ITUS also filed new litigation in a new subsidiary last Friday. | ||||
MARA announced favorable rulings in their medical device | ||||
portfolio in Germany. | ||||
PRKR announced Q3 2014 conference call and earnings | ||||
release will be held on November 10, 2014. | ||||
WILN announced they will move their headquarters from | ||||
Florida to California. | ||||
Filings: | ||||
MARA S-3 went effective. | ||||
Ticker | $CHG | %CHG | Volume | Closing |
Price | ||||
ACTG | $ (0.30) | -1.68% | 317,100 | $17.70 |
BCYP.OB | $ (0.0064) | -7.68% | 119,800 | $0.0769 |
CLGL (MVPI) | unch | unch | 100 | $0.43 |
COPY (ITUS) | unch | unch | 9,500 | $0.2000 |
CRDS | $ 0.0200 | 0.72% | 28,700 | $2.79 |
DSS | $ (0.0166) | -2.96% | 77,700 | $0.5433 |
EDIG.OB | $ 0.0021 | 5.77% | 49,300 | $0.039 |
ENIP | $ 0.0012 | 6.03% | 171,800 | $0.021 |
INVT (EONC) | $ 0.03 | 2.34% | 30,000 | $1.31 |
FNJN | $ (0.06) | -2.55% | 11,100 | $2.29 |
IDCC | $ 0.38 | 0.76% | 561,900 | $49.81 |
MARA | $ 0.43 | 3.36% | 74,700 | $13.23 |
MGT | $ (0.023) | -2.88% | 43,200 | $0.76 |
NTIP | unch | unch | 300 | $2.20 |
OTIV | $ 0.06 | 2.53% | 418,400 | $2.43 |
PCO | $ (0.09) | -5.39% | 176,700 | $1.58 |
PPRO | $ (0.04) | -1.57% | 100 | $2.50 |
PRKR | $ (0.01) | -0.76% | 332,000 | $1.30 |
PTNT | $ (0.11) | -3.72% | 1,200 | $2.97 |
RMBS | $ 0.06 | 0.49% | 706,500 | $11.51 |
SITO.OB | unch | unch | 27,500 | $0.295 |
SPEX | $ 0.0200 | 1.63% | 335,500 | $1.25 |
STRP | $ (1.34) | -6.20% | 101,300 | $20.26 |
TIVO | $ (0.03) | -0.23% | 1,104,100 | $13.02 |
TSRA | $ (0.53) | -1.76% | 756,000 | $29.86 |
UPIP | $ (0.09) | -5.81% | 487,800 | $1.46 |
VHC | $ (0.09) | -1.53% | 323,400 | $5.78 |
VRNG | $ (0.02) | -1.94% | 457,200 | $1.01 |
WDDD.OB | $ 0.00 | 1.00% | 80,300 | $0.1717 |
WILN | unch | unch | 75,700 | $3.32 |
Intellectual Property (IP) Publicly Traded Investment Companies - News, Analysis, Research
Monday, November 3, 2014
11/3/2014 Market Wrap
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment